1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxyla...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 413/10 (2006.01) A61K 31/4245 (2006.01) C07D 413/14 (2006.01)

Patent

CA 2488117

The present invention encompasses compounds of Formula I: as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. Pharmaceutical compositions and methods of use are included.

L'invention concerne des composés représentés par la formule I ainsi que leurs sels et leurs hydrates pharmaceutiquement acceptables. Ces composés sont utiles pour le traitement de maladies et d'affections d'origine immunologique, telles que le rejet de transplantation de la moelle osseuse, d'un organe ou d'un tissu. L'invention concerne également des compositions pharmaceutiques et les méthodes d'utilisation desdites compositions.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxyla... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxyla..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxyla... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1536740

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.